about
IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosaThe antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cellsDegenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15Zik1, a transcriptional repressor that interacts with the heterogeneous nuclear ribonucleoprotein particle K proteinMUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progressionMucins: a new family of epigenetic biomarkers in epithelial cancers.Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking.Combined NADPH oxidase 1 and interleukin 10 deficiency induces chronic endoplasmic reticulum stress and causes ulcerative colitis-like disease in miceComplex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathwaysThe MUC4 membrane-bound mucin regulates esophageal cancer cell proliferation and migration properties: Implication for S100A4 protein.Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFκB binding to ST8SIA1 promoter.Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.Metaplasia--a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia.Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathwaysTumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression.The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway.On the epigenetic origin of cancer stem cells.Mucins and pancreatic cancer.Mucins and tumor resistance to chemotherapeutic drugs.Identification of a 42-kDa nuclear factor (NF1-MUC5B) from HT-29 MTX cells that binds to the 3' region of human mucin gene MUC5B.Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells.Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting.The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase.Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer.The MUC1 mucin regulates the tumorigenic properties of human esophageal adenocarcinomatous cells.miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.Operatively induced chronic reflux in rats: a suitable model for studying esophageal carcinogenesis?
P50
Q24298035-5026CC67-EDA3-4FEB-B85F-D9ECFC431276Q24528155-16ED8B91-F826-4E71-874F-07E6FD747E3EQ28115549-37C25C5C-24A1-4C72-9514-C6E439A83AD8Q28296204-84755A94-74BB-4373-A5AA-4A880580091FQ28578563-E68009B1-6ADE-443F-A41D-6906E3CE90D4Q30597703-E1B87B70-9D40-401B-B9F9-BAF3E8750A7BQ30990417-B22160D4-A45E-4C7F-9B5E-606658A3D05BQ33441696-8C8ABDE5-D4DE-40BF-862B-CBB3A5E9039BQ33875033-D31A2BFB-CAC6-4D8A-88C1-C88DB765D8C4Q34157489-1D2B3A04-BB7C-48E4-AA61-47F3621CCFD7Q34185812-6A036869-33D4-40D5-A92C-B02F1E33EA73Q34213268-444D8541-8C78-42AF-9123-174F9EED875AQ34386496-E8ACCE02-B88F-4ECD-A24F-64E864D37A4DQ34693290-DF514BB3-FC00-40E7-89C7-C71D7ECCCA65Q35223880-24239094-FFFF-4058-8554-7A51B8C796A3Q35793641-E502B8D4-9153-48EB-9865-92A638B76ECCQ36541345-C4E81377-5352-47DD-B4CD-6B72E36D12A8Q36641184-E71D97B2-B04E-4C0B-85DE-343EA4D10452Q37001526-CF70DFAC-2875-4C48-A061-2583D7D776FBQ37330687-F5C26A49-1496-4E60-8211-C0B0760B01C3Q37605606-83AEBF25-5142-4D69-ACD8-CE9210063E80Q37611966-416692C4-738D-4522-9313-CFB85620A3B8Q37612156-5A891AE1-FD27-468A-BA9E-13ED915F2167Q37718458-C0A0C420-E417-47E6-AB8B-AED51A2C5177Q38001857-916130DF-A4E8-4CCD-88E4-73C584B6B613Q38166583-0063A0CE-4B35-481E-8E3E-02A8CBFF405CQ38208450-630FD082-D1C3-4CE3-9BDE-919F19912226Q38360670-FC658168-ACD1-4546-8BCF-8B73816954A8Q38499582-901ED7B5-2698-43B0-A1D0-7066EF727219Q38697133-ACE62412-7882-41DA-80C3-005EFC40C130Q38713917-5759820D-959E-4712-8531-0FFF62F3C818Q38826805-902A3155-58C5-45AF-93DA-772338A3A213Q38861713-78E32EF1-A7BE-4EA2-A8B6-A45B3E2061B1Q38868253-46FD77A3-1017-48BF-A036-22E2AD689B53Q38928294-197CA69C-5971-4D1C-A5DE-7DC3E52D3BFCQ38939839-BF06726D-D4AE-46F4-A90A-759F888AEEB6Q38977225-A396203D-E5C6-41B9-A64D-F455B3B4DA0AQ39017335-CE8B8BEB-C7BE-4B66-A1E2-52CF87B42B6FQ39037875-158820D9-B6C4-4111-BC3C-A29CEF7331E1Q39089169-CEE1DB75-6F93-4CA3-B4B7-E1D0A050E6AB
P50
description
researcher, ORCID id # 0000-0002-3131-2694
@en
wetenschapper
@nl
name
Isabelle Van Seuningen
@ast
Isabelle Van Seuningen
@en
Isabelle Van Seuningen
@es
Isabelle Van Seuningen
@nl
type
label
Isabelle Van Seuningen
@ast
Isabelle Van Seuningen
@en
Isabelle Van Seuningen
@es
Isabelle Van Seuningen
@nl
prefLabel
Isabelle Van Seuningen
@ast
Isabelle Van Seuningen
@en
Isabelle Van Seuningen
@es
Isabelle Van Seuningen
@nl
P106
P21
P31
P496
0000-0002-3131-2694